• Research Tree
  • Features
  • Pricing
  • Events
  • Reg.News
  • Short Interest
  • Explore Content
    • Explore

      • Providers
        • Providers

          • Free/Commissioned
          • High Net Worth Offering
          • Institutional Offering

          Free/Commissioned

          Research that is free to access for all investors. Companies commission these providers to write research about them.

          View Research

          What is our Main Bundle Offering?

          Brokers who write research on their corporate clients and make it available through our main bundle offering.

          View Research

          What is Institutional?

          Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.

          View Research
      • Regions
        • Regions

          • UK
          • Rest of EMEA
          • N America
          • APAC
          • LatAm
      • Exchanges
        • Exchanges

          • Aquis Apex
          • Australian Securities Exchange
          • Canadian Securities Exchange
          • Euronext Paris
          • London Stock Exchange (domestic)
          • SIX Swiss Exchange
      • Sectors
        • Sector Coverage

          • Building & Construction
          • Discretionary Personal Goods
          • Discretionary Retail
          • Energy
          • Health
          • Investment Trusts
          • Media
          • Resources
          • Technology
      • Small / Large Cap
        • Small / Large Cap

          • UK100
          • UK250
          • UK Smallcap
          • UK Other Main Markets
          • Other
  • Login
  • Sign Up
LIVE

Event in Progress:

Join Here ×

working
  • 26 Aug 2025

Nutrien 2Q25: Strong Potash and Nitrogen Results Support Margin Growth


Nutrien Ltd. (NTR:TSE) | 0 0 0.0%


  • Hypothesis Research
    • Marina Alekseenkova

    • 5 pages


 

 Nutrien reported net earnings of $1,229mn in 2Q25, up from $392mn a year ago, with diluted net earnings per share of $2.50, compared to $0.74 in 2Q24. The primary drivers were a 12% YoY increase in potash sales volumes, a 30% YoY rise in offshore potash prices, a 7% YoY increase in nitrogen sales volumes, and an 11% rise in urea prices. In the Phosphates segment, higher fertilizer prices offset lower sales volumes. Total sales rose 3% YoY to $10,438mn, while Adjusted EBITDA increased 11% YoY to $2,486mn. The company cut expenses by 33% YoY to $1,393mn. Retail sales declined 1% YoY to $7,959mn, mainly due to lower crop protection products and seed sales. Higher volumes and selling prices in North America were partly offset by weaker sales volumes in Australia due to hot weather. The average retail price increased 2% YoY. Retail Adjusted EBITDA reached $1,149mn, up 2% YoY. The Potash segment net sales rose 31% YoY to $991mn, driven by a 12% increase in volumes to 3.989mt, and a 17% rise in average potash prices, with offshore sales prices up 30% YoY. Potash gross margin rose 24%YoY, while cash costs were $55/t, up 10% YoY and down from $60/t in 1Q25. Potash Adjusted EBITDA climbed 33% YoY to $630mn in 2Q. Nitrogen net sales grew 23% YoY to $1,260mn, supported by 7% higher volumes, a 14% increase in urea prices, and a 21% YoY rise in solutions and nitrates price. Ammonia prices were up just 1% YoY. Despite a 20% increase in gas costs per MMBtu, nitrogen gross margin expanded 27% YoY, and Adjusted EBITDA increased 12% YoY to $667mn. In the Phosphates segment, net sales rose 1% YoY to $396mn, as an 11% YoY price increase offset a 7% YoY decline in sales volumes. Gross margin improved by 5% YoY, and Adjusted EBITDA rose 5% YoY to $92mn. Cash from operating activities jumped 40% YoY to $2,538mn, while cash used in investing activities fell 19% YoY to $495mn. The company returned $373mn to shareholders through dividends and share repurchases. Net debt stood at $12,251mn, nearly flat YoY.  Nutrien raised its potash sales guidance for FY25 from 13.6–14.4 mt to 13.9–14.5 mt, while maintaining forecasts for Retail Adjusted EBITDA and Nitrogen and Phosphate volumes. Nitrogen sales volumes are projected at 10.7–11.2 mt (up from 10.6 mt in 2024), while Phosphate volumes are expected between 2.35–2.55 mt (vs. 2.43 mt in 2024). Global potash shipments are projected at 73–75 mt in 2025, compared to 72.5 mt in 2024. Strong 1Q25 demand supported both potash pricing and volumes, and Nutrien noted historically low US nitrogen producer inventories entering 2H25.  Reflecting a positive outlook for the nitrogen and potash markets, we have updated our forecasts. Fertilizer producers report robust demand, supported by higher prices and improved potash contract margins in India and China. We have raised our DCF-based 12-month price target to US$65.4 (from US$61.1) and reaffirm our ‘Buy’ rating on the stock.

Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here
See all the research we have on this company.

Nutrien 2Q25: Strong Potash and Nitrogen Results Support Margin Growth


Nutrien Ltd. (NTR:TSE) | 0 0 0.0%


  • Published: 26 Aug 2025
  • Author: Marina Alekseenkova
  • Pages: 5
  • Hypothesis Research


 Nutrien reported net earnings of $1,229mn in 2Q25, up from $392mn a year ago, with diluted net earnings per share of $2.50, compared to $0.74 in 2Q24. The primary drivers were a 12% YoY increase in potash sales volumes, a 30% YoY rise in offshore potash prices, a 7% YoY increase in nitrogen sales volumes, and an 11% rise in urea prices. In the Phosphates segment, higher fertilizer prices offset lower sales volumes. Total sales rose 3% YoY to $10,438mn, while Adjusted EBITDA increased 11% YoY to $2,486mn. The company cut expenses by 33% YoY to $1,393mn. Retail sales declined 1% YoY to $7,959mn, mainly due to lower crop protection products and seed sales. Higher volumes and selling prices in North America were partly offset by weaker sales volumes in Australia due to hot weather. The average retail price increased 2% YoY. Retail Adjusted EBITDA reached $1,149mn, up 2% YoY. The Potash segment net sales rose 31% YoY to $991mn, driven by a 12% increase in volumes to 3.989mt, and a 17% rise in average potash prices, with offshore sales prices up 30% YoY. Potash gross margin rose 24%YoY, while cash costs were $55/t, up 10% YoY and down from $60/t in 1Q25. Potash Adjusted EBITDA climbed 33% YoY to $630mn in 2Q. Nitrogen net sales grew 23% YoY to $1,260mn, supported by 7% higher volumes, a 14% increase in urea prices, and a 21% YoY rise in solutions and nitrates price. Ammonia prices were up just 1% YoY. Despite a 20% increase in gas costs per MMBtu, nitrogen gross margin expanded 27% YoY, and Adjusted EBITDA increased 12% YoY to $667mn. In the Phosphates segment, net sales rose 1% YoY to $396mn, as an 11% YoY price increase offset a 7% YoY decline in sales volumes. Gross margin improved by 5% YoY, and Adjusted EBITDA rose 5% YoY to $92mn. Cash from operating activities jumped 40% YoY to $2,538mn, while cash used in investing activities fell 19% YoY to $495mn. The company returned $373mn to shareholders through dividends and share repurchases. Net debt stood at $12,251mn, nearly flat YoY.  Nutrien raised its potash sales guidance for FY25 from 13.6–14.4 mt to 13.9–14.5 mt, while maintaining forecasts for Retail Adjusted EBITDA and Nitrogen and Phosphate volumes. Nitrogen sales volumes are projected at 10.7–11.2 mt (up from 10.6 mt in 2024), while Phosphate volumes are expected between 2.35–2.55 mt (vs. 2.43 mt in 2024). Global potash shipments are projected at 73–75 mt in 2025, compared to 72.5 mt in 2024. Strong 1Q25 demand supported both potash pricing and volumes, and Nutrien noted historically low US nitrogen producer inventories entering 2H25.  Reflecting a positive outlook for the nitrogen and potash markets, we have updated our forecasts. Fertilizer producers report robust demand, supported by higher prices and improved potash contract margins in India and China. We have raised our DCF-based 12-month price target to US$65.4 (from US$61.1) and reaffirm our ‘Buy’ rating on the stock.

More Content

More Content

Nutrien1Q25: Robust Potash Volumes with QoQ Price Improvement

Companies: Nutrien Ltd.

Hypothesis Research

Nutrien 1Q23: prices down to mid-cycle averages

Companies: Nutrien Ltd.

Hypothesis Research

Nutrien 4Q24: Strong Volumes and Lower Costs Support EBITDA

Companies: Nutrien Ltd.

Hypothesis Research

Nutrien 2Q23: guidance downgraded but the demand is promising

Companies: Nutrien Ltd.

Hypothesis Research

Nutrien 2Q24: higher operating rates and lower costs

Companies: Nutrien Ltd.

Hypothesis Research
Research Tree
Useful Links
  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub
  • Stock Pick League
  • Chrome Extension
  • iOS and Android Apps
  • LLM Feed
Account
  • Login
  • Join Now
  • Contact
  • Follow us on Linkedin
  • Follow us on X

© Research Tree 2025

  • Apple Store
  • Play Store
  • Terms of Service
  • Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • ETFs
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Investment Trusts
      • Leisure, Tourism & Travel
      • Media
      • Open-ended Funds
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Actinver
      • Actio Advisors
      • Asset TV
      • Astris Advisory
      • Atrium Research
      • Baden Hill
      • BlytheRay
      • BNP Paribas Exane - Sponsored Research
      • Bondcritic
      • Bowsprit Partners Limited
      • Brand Communications
      • Brokerlink
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Capital Link
      • Capital Markets Brokers
      • Cavendish
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Doceo
      • Edison
      • Engage Investor
      • Equity Development
      • eResearch
      • First Equity
      • Five Minute Pitch TV
      • focusIR
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • goetzpartners securities Limited
      • Golden Section Capital
      • GreenSome Finance
      • GSBR Research
      • H2 Radnor
      • Hardman & Co
      • Holland Advisors
      • Hypothesis Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Longspur Clean Energy
      • Mello Events
      • Messari Research
      • MUFG Corporate Markets IR
      • Nippon Investment Bespoke Research UK
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Optimo Capital
      • Panmure Liberum
      • Paul Scott
      • Peel Hunt
      • PIWORLD / Progressive
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • Research Dynamics
      • Research Tree
      • Resolve Research
      • SEAL Advisors Ltd
      • ShareSoc
      • Shore Capital
      • Sidoti & Company
      • Small Cap Consumer Research LLC
      • StockBox
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Edge Group
      • The Life Sciences Division
      • Trinity Delta
      • Turner Pope Investments
      • UK Investor Group
      • ValueTrack
      • Vox Markets
      • VRS International S.A. - Valuation & Research Specialists (VRS)
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Yaru Investments
      • Yellowstone Advisory
      • Zacks Small Cap Research
      • Zeus Capital
    • High Net Worth Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Acquisdata
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • First Berlin
      • First Equity
      • First Sentinel
      • Greenwood Capital Partners
      • Hannam & Partners
      • Hybridan
      • Kemeny Capital
      • Longspur Clean Energy
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • Tennyson Securities
      • The Life Sciences Division
      • Turner Pope Investments
      • VSA Capital
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • ABG Sundal Collier
      • ACF Equity Research
      • Allenby Capital
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • BNP Paribas Exane
      • Bondcritic
      • Canaccord Genuity
      • Capital Access Group
      • Capital Link
      • Cavendish
      • Couloir Capital
      • Degroof Petercam
      • Dowgate Capital
      • Edison
      • First Berlin
      • First Equity
      • First Sentinel
      • Five Minute Pitch TV
      • Fundamental Research Corp
      • Galliano’s Latin Notes
      • GBC AG
      • Golden Section Capital
      • Goodbody
      • Greenwood Capital Partners
      • Hannam & Partners
      • Holland Advisors
      • Hybridan
      • InterAxS Global
      • Investec Bank
      • Kepler | Trust Intelligence
      • Numis
      • NuWays
      • OAK Securities
      • Oberon Capital
      • Panmure Liberum
      • Peel Hunt
      • QuotedData
      • QuotedData Professional
      • Research Dynamics
      • Research Tree
      • Shard Capital
      • Shore Capital
      • Sidoti & Company
      • Singer Capital Markets
      • Small Cap Consumer Research LLC
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • StockBox
      • Tamesis Partners
      • Tennyson Securities
      • The AIC
      • The Business Magazine Group
      • The Life Sciences Division
      • ValueTrack
      • Velocity Trade
      • VSA Capital
      • Winterflood Securities
      • World Platinum Investment Council
      • Zacks Small Cap Research
      • Zeus Capital
  • Contact
  • Sign Up
  • Sign In